$OPEN
Opendoor Technologies Inc. Stock $open

$open Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000180116923000055 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.976B	$3.120B
YoY Change	-52.93%	-39.43%
Cost Of Revenue	$1.827B	$2.950B
YoY Change	-50.78%	-36.09%
Gross Profit	$149.0M	$170.0M
YoY Change	-69.34%	-68.22%
Gross Profit Margin	7.54%	5.45%
Selling, General & Admin	$168.0M	$254.0M
YoY Change	-59.32%	-32.63%
% of Gross Profit	112.75%	149.41%
Research & Development	$38.00M	$40.00M
YoY Change	-7.32%	0.0%
% of Gross Profit	25.5%	23.53%
Depreciation & Amortization	$17.00M	$10.00M
YoY Change	88.89%	11.11%
% of Gross Profit	11.41%	5.88%
Operating Expenses	$206.0M	$294.0M
YoY Change	-54.63%	-29.5%
Operating Profit	-$57.00M	-$124.0M
YoY Change	-278.13%	-205.08%
Interest Expense	-$53.00M	$74.00M
YoY Change	-159.55%	8.82%
% of Operating Profit
Other Income/Expense, Net	$41.00M	$19.00M
YoY Change	925.0%	-186.36%
Pretax Income	$24.00M	-$101.0M
YoY Change	-145.28%	-460.71%
Income Tax	$1.000M	$300.0K
% Of Pretax Income	4.17%
Net Earnings	$23.00M	-$101.0M
YoY Change	-142.59%	-460.71%
Net Earnings / Revenue	1.16%	-3.24%
Basic Earnings Per Share	$0.04	-$0.16
Diluted Earnings Per Share	$0.03	-$0.16
COMMON SHARES
Basic Shares Outstanding	648.8M shares	642.6M shares
Diluted Shares Outstanding	667.2M shares	641.9M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.210B	$1.251B
YoY Change	-51.05%	-54.94%
Cash & Equivalents	$1.120B	$1.143B
Short-Term Investments	$90.00M	$108.0M
Other Short-Term Assets	$1.721B	$46.00M
YoY Change	962.35%	-63.49%
Inventory	$1.149B	$2.118B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.093B	$4.972B
YoY Change	-58.84%	-38.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$90.00M	$59.00M
YoY Change	66.67%	20.41%
Goodwill	$4.000M	$4.000M
YoY Change	-93.33%	-93.33%
Intangibles	$9.000M	$11.00M
YoY Change	28.57%	10.0%
Long-Term Investments
YoY Change
Other Assets	$27.00M	$27.00M
YoY Change	0.0%	-6.9%
Total Long-Term Assets	$130.0M	$140.0M
YoY Change	-31.94%	-27.46%
TOTAL ASSETS
Total Short-Term Assets	$4.093B	$4.972B
Total Long-Term Assets	$130.0M	$140.0M
Total Assets	$4.223B	$5.112B
YoY Change	-58.34%	-38.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.00M	$77.00M
YoY Change	-69.77%	-41.67%
Accrued Expenses	$8.000M	$11.00M
YoY Change	-52.94%	-8.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$15.00M	$355.0M
YoY Change	-99.56%	-86.7%
Total Short-Term Liabilities	$88.00M	$443.0M
YoY Change	-97.56%	-84.26%
LONG-TERM LIABILITIES
Long-Term Debt	$3.028B	$3.598B
YoY Change	-26.72%	17.28%
Other Long-Term Liabilities	$21.00M	$35.00M
YoY Change	-50.0%	-18.6%
Total Long-Term Liabilities	$3.049B	$3.633B
YoY Change	-26.95%	16.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.00M	$443.0M
Total Long-Term Liabilities	$3.049B	$3.633B
Total Liabilities	$3.137B	$4.076B
YoY Change	-59.68%	-31.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.136B	-$3.159B
YoY Change	81.17%	88.37%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.086B	$1.036B
YoY Change
Total Liabilities & Shareholders Equity	$4.223B	$5.112B
YoY Change	-58.34%	-38.2%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$23.00M	-$101.0M
YoY Change	-142.59%	-460.71%
Depreciation, Depletion And Amortization	$17.00M	$10.00M
YoY Change	88.89%	11.11%
Cash From Operating Activities	$940.0M	$2.162B
YoY Change	-149.66%	39.48%
INVESTING ACTIVITIES
Capital Expenditures	$9.000M	$8.000M
YoY Change	-190.0%	-20.0%
Acquisitions
YoY Change
Other Investing Activities	$24.00M	$38.00M
YoY Change	-89.61%	-235.71%
Cash From Investing Activities	$15.00M	$30.00M
YoY Change	-93.21%	-178.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-809.0M	-$1.325B
YoY Change	-145.71%	-0.67%
NET CHANGE
Cash From Operating Activities	940.0M	$2.162B
Cash From Investing Activities	15.00M	$30.00M
Cash From Financing Activities	-809.0M	-$1.325B
Net Change In Cash	146.0M	$867.0M
YoY Change	48.98%	387.08%
FREE CASH FLOW
Cash From Operating Activities	$940.0M	$2.162B
Capital Expenditures	$9.000M	$8.000M
Free Cash Flow	$931.0M	$2.154B
YoY Change	-149.44%	39.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Tempe,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001801169
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2023Q1	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39253
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Opendoor Technologies Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-1318214
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	410 N. Scottsdale Road,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1600
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85281
CY2023Q1	dei	City Area Code CityAreaCode	480
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	618-6760
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	OPEN
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	648777275	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1143000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1137000000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1515000000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	654000000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	108000000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	144000000	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	42000000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	30000000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	2118000000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	4460000000	usd
CY2023Q1	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	0	usd
CY2022Q4	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	1000000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	46000000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	41000000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4972000000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6466000000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58000000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39000000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41000000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4000000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12000000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27000000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27000000	usd
CY2023Q1	us-gaap	Assets Assets	5112000000	usd
CY2022Q4	us-gaap	Assets Assets	6608000000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	77000000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	110000000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	355000000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1376000000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	4000000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12000000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7000000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	443000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1505000000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	2824000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3020000000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	774000000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	959000000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38000000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4076000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5522000000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	647607920	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	637387025	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	647607920	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	637387025	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4198000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4148000000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3159000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3058000000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1036000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1086000000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4000000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5112000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6608000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3120000000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5151000000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2950000000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	4616000000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	170000000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	535000000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	188000000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	276000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66000000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	101000000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40000000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40000000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	294000000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	417000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-124000000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	118000000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	78000000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	74000000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	68000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-101000000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	28000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-101000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	28000000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	641916000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	619137000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	641916000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	640785000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-101000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	28000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-100000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1086000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-101000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1036000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2248000000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	71000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	28000000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2347000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-101000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	28000000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	22000000	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	18000000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2000000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	42000000	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	67000000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	23000000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	8000000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1000000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-22000000	usd
CY2023Q1	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	0	usd
CY2022Q1	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	1000000	usd
CY2023Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	0	usd
CY2022Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	46000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	1000000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	43000000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	78000000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	12000000	usd
CY2022Q1	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	-26000000	usd
CY2023Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-2306000000	usd
CY2022Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-1416000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10000000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	28000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22000000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2000000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-8000000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-5000000	usd
CY2023Q1	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2000000	usd
CY2022Q1	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2162000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1550000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	28000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	38000000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	22000000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	25000000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	3000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	30000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38000000	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	101000000	usd
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1000000	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	224000000	usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2292000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1446000000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M6D
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3622000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	45000000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	41000000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10000000	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	4000000	usd
CY2022Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1325000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1334000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	867000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	178000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1791000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2578000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2658000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2756000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	74000000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	68000000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	6000000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1143000000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2312000000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	1515000000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	444000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2658000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2756000000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that have a material impact on the amounts reported in the financial statements and accompanying notes. Significant estimates, assumptions and judgments made by management include, among others, the determination of the fair value of common stock, share-based awards, warrants, and inventory valuation adjustment. Management believes that the estimates and judgments upon which management relies are reasonable based upon information available to management at the time that these estimates and judgments are made. To the extent there are material differences between these estimates, assumptions and judgments and actual results, the carrying values of the Company's assets and liabilities and the results of operations will be affected. The health of the residential housing market and interest rate environment have introduced additional uncertainty with respect to judgments, estimates and assumptions, which may materially impact the estimates previously listed, among others.</span></div>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, and investments in marketable securities. The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company’s investments.</span></div>
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2000000	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2000000	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	187000000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	459000000	usd
CY2023Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	158000000	usd
CY2022Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	891000000	usd
CY2023Q1	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	999000000	usd
CY2022Q4	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	2788000000	usd
CY2023Q1	open	Inventory Real Estate In Resale Contract InventoryRealEstateInResaleContract	961000000	usd
CY2022Q4	open	Inventory Real Estate In Resale Contract InventoryRealEstateInResaleContract	781000000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	2118000000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	4460000000	usd
CY2023Q1	us-gaap	Recorded Unconditional Purchase Obligation Minimum Quantity Required RecordedUnconditionalPurchaseObligationMinimumQuantityRequired	1137	home
CY2023Q1	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	346000000	usd
CY2023Q1	open	Inventory Real Estate Valuation Adjustment Decrease Increase InventoryRealEstateValuationAdjustmentDecreaseIncrease	23000000	usd
CY2022Q1	open	Inventory Real Estate Valuation Adjustment Decrease Increase InventoryRealEstateValuationAdjustmentDecreaseIncrease	8000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	12000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	12000000	usd
CY2023Q1	open	Equity Securities Fvni Cash And Cash Equivalents EquitySecuritiesFVNICashAndCashEquivalents	0	usd
CY2023Q1	open	Equity Securities Fvni Marketable Securities EquitySecuritiesFVNIMarketableSecurities	12000000	usd
CY2023Q1	open	Cash Cash Equivalents And Marketable Securities Amortized Cost CashCashEquivalentsAndMarketableSecuritiesAmortizedCost	1254000000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3000000	usd
CY2023Q1	open	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	1251000000	usd
CY2023Q1	open	Marketable Securities Cash And Cash Equivalents MarketableSecuritiesCashAndCashEquivalents	1143000000	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	108000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	11000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	11000000	usd
CY2022Q4	open	Equity Securities Fvni Cash And Cash Equivalents EquitySecuritiesFVNICashAndCashEquivalents	0	usd
CY2022Q4	open	Equity Securities Fvni Marketable Securities EquitySecuritiesFVNIMarketableSecurities	11000000	usd
CY2022Q4	open	Cash Cash Equivalents And Marketable Securities Amortized Cost CashCashEquivalentsAndMarketableSecuritiesAmortizedCost	1285000000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000000	usd
CY2022Q4	open	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	1281000000	usd
CY2022Q4	open	Marketable Securities Cash And Cash Equivalents MarketableSecuritiesCashAndCashEquivalents	1137000000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	144000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1000000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-22000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	4000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	87000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	91000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	11000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	119000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	130000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4000000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	96000000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	72000000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	24000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	19000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	20000000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5000000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	24000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	25000000	usd
CY2023Q1	us-gaap	Other Restricted Assets OtherRestrictedAssets	500000000	usd
CY2022Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	565000000	usd
CY2021Q3	open	Option Indexed To Issuers Equity Cap Price Premium OptionIndexedToIssuersEquityCapPricePremium	1
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	159000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	148000000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	100000000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	90000000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10000000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9000000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.29
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10712000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.13
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1335000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.01
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	11000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9366000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.29
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9366000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42000000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0026
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0100
CY2022Q1	us-gaap	Dividends Dividends	0	usd
CY2023Q1	us-gaap	Dividends Dividends	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-101000000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28000000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	641916000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	619137000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-101000000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28000000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	641916000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	619137000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	641916000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	640785000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	89578000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36623000	shares

Files In Submission

Name	View Source	Status
0001801169-23-000055-index-headers.html	Edgar Link	pending
0001801169-23-000055-index.html	Edgar Link	pending
0001801169-23-000055.txt	Edgar Link	pending
0001801169-23-000055-xbrl.zip	Edgar Link	pending
a101offerletteragreementda.htm	Edgar Link	pending
a102offerletteragreementda.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
open-20230331.htm	Edgar Link	pending
open-20230331.xsd	Edgar Link	pending
q12023exhibit311.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
open-20230331_cal.xml	Edgar Link	unprocessable
open-20230331_def.xml	Edgar Link	unprocessable
open-20230331_lab.xml	Edgar Link	unprocessable
open-20230331_pre.xml	Edgar Link	unprocessable
open-20230331_htm.xml	Edgar Link	completed
q12023exhibit312.htm	Edgar Link	pending
q12023exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPEN
Opendoor Technologies Inc. Stock $open

2023 Q2 Form 10-Q Financial Statement

#000180116923000055 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN Opendoor Technologies Inc. Stock $open

2023 Q2 Form 10-Q Financial Statement

#000180116923000055 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN
Opendoor Technologies Inc. Stock $open